Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer

A CME Program During The 2017 IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology

Year in Review — A Multitumor Regional Symposia Series Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers

Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Breast Cancer – December 6, 2017, San Antonio, Texas

Addressing Current Questions and Controversies in the Management of Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis

A 2-Part Friday Satellite Symposia Series Preceding the 59^th ASH Annual Meeting

The 15^th Annual Winter Lung Cancer Conference